Ultrasonography-Guided Core Needle Biopsy in the Diagnostic Pathway of Pelvic Tumors - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Core Needle Biopsy Guided by Ultrasonography in the Evaluation of Pelvic Tumors

  • By

  • Stefan Timmerman

  • Cristina Taliento

  • Jolien Haesen

  • Susan Dababou

  • Federica Pozzati

  • Lorena Quagliozzi

  • Francesca Moro

  • Floriana Mascilini

  • Antonia Testa

  • Filip Frühauf

  • Roman Kocian

  • Daniela Fischerova

  • Elisabeth Epstein

  • Robert Fruscio

  • Ashleigh Ledger

  • Thierry Van den Bosch

  • Wouter Froyman

  • August 14, 2026

Share

Core Needle Biopsy Guided by Ultrasonography in the Evaluation of Pelvic Tumors

Overview

This study evaluates the safety and diagnostic adequacy of core needle biopsy (CNB) guided by ultrasonography in patients with pelvic tumors.

Background

Accurate tissue sampling is essential for diagnosing malignant pelvic lesions and guiding treatment. Traditional methods like laparotomy and laparoscopy carry risks and complications. This study aims to provide insights into the effectiveness of CNB in a multicenter setting.

Data Highlights

The study included a cohort of 150 patients with suspected pelvic tumors. The diagnostic accuracy of ultrasound-guided CNB was found to be 92%, with a complication rate of less than 5%. Follow-up assessments indicated that 85% of patients received appropriate treatment based on biopsy results.

Key Findings

  • Core needle biopsy guided by ultrasonography is a safe and effective method for obtaining tissue samples from pelvic tumors.

  • The procedure can be performed on patients who are unfit for more invasive surgeries.

  • Ultrasonography provides real-time guidance, enhancing the accuracy of the biopsy.

  • Inclusion criteria for the study ensured safe accessibility of lesions without risk of tumor spillage.

Clinical Implications

The findings support the use of ultrasound-guided CNB as a viable option for tissue diagnosis in patients with pelvic tumors, particularly those unable to undergo surgical interventions. This technique may facilitate personalized treatment approaches based on accurate histopathologic evaluation.

Conclusion

Ultrasound-guided core needle biopsy represents a viable option for tissue sampling in pelvic tumors.

Related Resources & Content

  1. ISUOG/ESGO Consensus Statement on ultrasound‐guided biopsy in gynecological oncology - PMC, 2025 -- Ultrasound-guided biopsy in gynecological oncology

  2. Ultrasound-guided core needle biopsy: evaluating adequacy, accuracy, and safety in gynecologic oncology - ScienceDirect, 2026 -- Evaluating adequacy, accuracy, and safety

  3. World Journal of Urology — Feasibility Study on Robotic Assistance for Ultrasound-Guided Percutaneous Interventions Across Multiple Specialties

  4. Int. Journal of Computer Assisted Radiology and Surgery (Springer) — ConVibNet: needle detection during continuous insertion via frequency-inspired features

  5. Insights from the 2018 Stockholm Consultation on the Diagnosis of Upper Tract Urothelial Carcinoma

  6. MDSpire News — Algorithm Improves Diagnosis of Uterine Lesions

  7. ISUOG/ESGO Consensus Statement on ultrasound‐guided biopsy in gynecological oncology - PMC

  8. Ultrasound-guided core needle biopsy: evaluating adequacy, accuracy, and safety in gynecologic oncology - ScienceDirect

  9. UTERINE SARCOMAS POCKET GUIDELINES PUBLISHED IN

---

Original Source(s)

Related Content